Alnylam Pharmaceuticals (ALNY) Interest & Investment Income (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Interest & Investment Income of $28.14 million for Q2 2026, up 2.4% from $27.49 million a year earlier and up 5.8% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Interest & Investment Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Alnylam Pharmaceuticals was $110.05 million, down 7.8% year-over-year; for FY2025, it came in at $111.47 million, down 8.6% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 56.7% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Interest & Investment Income was $121.99 million in FY2024 (+27.7%), $95.56 million in FY2023 (+285.2%), $24.81 million in FY2022 and $1.58 million in FY2021 (-86.6%).
- Quarterly Interest & Investment Income has run from a low of $225,000 in Q3 2021 to a high of $32.15 million in Q3 2024 over five years.
- On a year-over-year basis, Interest & Investment Income increased in three of the last eight quarters, with an average decline of 1.3%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2022, with growth of 364.3%; the weakest was Q3 2021, with a decline of 89.1%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $26.6 million (Q1 2026), $26.63 million (Q4 2025) and $28.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 120.60 Mn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 28.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.14 Mn |
| Mar 31, 2026 | 26.60 Mn |
| Dec 31, 2025 | 26.63 Mn |
| Sep 30, 2025 | 28.68 Mn |
| Jun 30, 2025 | 27.49 Mn |
| Mar 31, 2025 | 28.67 Mn |
| Dec 31, 2024 | 31.02 Mn |
| Sep 30, 2024 | 32.15 Mn |
| Jun 30, 2024 | 29.18 Mn |
| Mar 31, 2024 | 29.65 Mn |
| Dec 31, 2023 | 30.41 Mn |
| Sep 30, 2023 | 25.43 Mn |
| Jun 30, 2023 | 21.08 Mn |
| Mar 31, 2023 | 18.66 Mn |
| Dec 31, 2022 | 14.08 Mn |
| Sep 30, 2022 | 7.82 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 495,000.00 |
| Sep 30, 2021 | 225,000.00 |
API Access
Alnylam Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();